Log in to save to my catalogue

Radiographic progression and remission rates in early rheumatoid arthritis – MRI bone oedema and ant...

Radiographic progression and remission rates in early rheumatoid arthritis – MRI bone oedema and ant...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_954575865

Radiographic progression and remission rates in early rheumatoid arthritis – MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial

About this item

Full title

Radiographic progression and remission rates in early rheumatoid arthritis – MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial

Publisher

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Journal title

Annals of the rheumatic diseases, 2010-10, Vol.69 (10), p.1789-1795

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd and European League Against Rheumatism

More information

Scope and Contents

Contents

Objective At 5 years' follow-up of early (<6 months) rheumatoid arthritis patients to (1) investigate whether initial combination therapy with methotrexate (MTX) and ciclosporin (CSA) (n=80) is superior to initial monotherapy with MTX (n=80) with respect to prevention of radiographic progression, (2) investigate whether the favourable clinical and...

Alternative Titles

Full title

Radiographic progression and remission rates in early rheumatoid arthritis – MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_954575865

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_954575865

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/ard.2009.125534

How to access this item